Cole Locklear, MD
Internal Medicine · Nashville, TNNPI 1972959211
Payments from drug & device makers
Across 84 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$378
- Pfizer$314
- Lilly USA, LLC$132
- AstraZeneca$80
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$67
- Boehringer Ingelheim$66
- plus $467 from 14 others
What the payments were for
- Food & beverage$1,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $378 |
| Pfizer | 18 | $314 |
| Lilly USA, LLC | 8 | $132 |
| AstraZeneca | 5 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Boehringer Ingelheim | 4 | $66 |
| Cequr Corporation | 2 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Exact Sciences | 3 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Inspire Medical Systems, Inc. | 1 | $44 |
| Abbott | 3 | $42 |
| Johnson & Johnson | 2 | $31 |
| Dynavax Technologies Corporation | 1 | $28 |
| AbbVie | 1 | $24 |
| Merck | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
How this compares
$1,503 in reported general payments places this provider in the 70th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 27 | $344 |
| Losartan Potassium | 27 | $315 |
| Rosuvastatin Calcium | 31 | $300 |
| Pantoprazole Sodium | 15 | $211 |
| Spironolactone | 12 | $155 |
| Gabapentin | 15 | $155 |
| Levothyroxine Sodium | 32 | $129 |
| Simvastatin | 12 | $106 |
| Lisinopril | 13 | $77 |
| Amlodipine Besylate | 17 | $59 |
| Hydrochlorothiazide | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Nashville
- John AndersonNashville$1.5M
- Nancy DavisNashville$985K
- Wayne RileyNashville$536K
- Paul FerrellNashville$413K
- Cyndya Shibao MiyasatoNashville$364K
- Hilary TindleNashville$337K
- Harvey BowlesNashville$203K
- Jay MontgomeryNashville$174K
- Temidayo AbeNashville$113K
- Nader BahriNashville$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.